This Speaker Series details highlights from a webcast presentation‘Changing treatment paradigm in patients with primary myelofibrosis, secondary myelofibrosis with intermediate-1 IPSS or DIPSS’ by Professor Francesco Passamonti May 30th 2017.
Please login below to download this issue (PDF)